QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
QQQ   277.20 (+2.08%)
AAPL   114.96 (+2.39%)
MSFT   209.44 (+0.78%)
FB   256.82 (+0.78%)
GOOGL   1,458.66 (+1.36%)
AMZN   3,174.05 (+2.55%)
TSLA   421.20 (+3.40%)
NVDA   521.40 (+1.25%)
BABA   276.01 (+1.81%)
CGC   14.21 (+0.28%)
GE   6.20 (+1.47%)
MU   49.72 (+1.18%)
AMD   79.48 (+1.82%)
T   28.38 (+1.21%)
F   6.69 (+2.76%)
ACB   4.78 (-5.35%)
GILD   62.85 (+0.96%)
NFLX   490.65 (+1.61%)
DIS   125.99 (+1.60%)
BA   166.08 (+6.44%)
BAC   24.09 (+2.55%)
Log in
NASDAQ:XTLB

X T L Biopharmaceuticals Stock Forecast, Price & News

$1.85
-0.01 (-0.54 %)
(As of 09/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.78
Now: $1.85
$1.88
50-Day Range
$1.61
MA: $1.85
$2.21
52-Week Range
$0.63
Now: $1.85
$2.35
Volume1,642 shs
Average Volume15,489 shs
Market Capitalization$9.51 million
P/E RatioN/A
Dividend YieldN/A
Beta0.91
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. XTL Biopharmaceuticals Ltd. has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Ramat Gan, Israel.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:XTLB
CUSIPN/A
Phone972-9955-7080

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.36 per share

Profitability

Net Income$-1,350,000.00

Miscellaneous

EmployeesN/A
Market Cap$9.51 million
Next Earnings Date11/25/2020 (Estimated)
OptionableNot Optionable
$1.85
-0.01 (-0.54 %)
(As of 09/28/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XTLB News and Ratings via Email

Sign-up to receive the latest news and ratings for XTLB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











X T L Biopharmaceuticals (NASDAQ:XTLB) Frequently Asked Questions

How has X T L Biopharmaceuticals' stock been impacted by COVID-19?

X T L Biopharmaceuticals' stock was trading at $1.03 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, XTLB stock has increased by 79.6% and is now trading at $1.85.
View which stocks have been most impacted by COVID-19
.

When is X T L Biopharmaceuticals' next earnings date?

X T L Biopharmaceuticals is scheduled to release its next quarterly earnings announcement on Wednesday, November 25th 2020.
View our earnings forecast for X T L Biopharmaceuticals
.

How were X T L Biopharmaceuticals' earnings last quarter?

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB) announced its quarterly earnings results on Monday, August, 24th. The biopharmaceutical company reported ($0.08) earnings per share (EPS) for the quarter.
View X T L Biopharmaceuticals' earnings history
.

When did X T L Biopharmaceuticals' stock split? How did X T L Biopharmaceuticals' stock split work?

Shares of X T L Biopharmaceuticals reverse split on the morning of Friday, February 10th 2017. The 1-5 reverse split was announced on Wednesday, January 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 9th 2017. An investor that had 100 shares of X T L Biopharmaceuticals stock prior to the reverse split would have 20 shares after the split.

Are investors shorting X T L Biopharmaceuticals?

X T L Biopharmaceuticals saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 5,800 shares, an increase of 65.7% from the August 31st total of 3,500 shares. Based on an average trading volume of 19,100 shares, the short-interest ratio is currently 0.3 days.
View X T L Biopharmaceuticals' Short Interest
.

Who are some of X T L Biopharmaceuticals' key competitors?

What other stocks do shareholders of X T L Biopharmaceuticals own?

Who are X T L Biopharmaceuticals' key executives?

X T L Biopharmaceuticals' management team includes the following people:
  • Mr. Joshua Levine, Chief Exec. Officer (Age 53)
  • Mr. Itay Weinstein, Chief Financial Officer (Age 48)
  • Mr. Ronen Kantor Adv, Company Sec.

What is X T L Biopharmaceuticals' stock symbol?

X T L Biopharmaceuticals trades on the NASDAQ under the ticker symbol "XTLB."

How do I buy shares of X T L Biopharmaceuticals?

Shares of XTLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is X T L Biopharmaceuticals' stock price today?

One share of XTLB stock can currently be purchased for approximately $1.85.

How big of a company is X T L Biopharmaceuticals?

X T L Biopharmaceuticals has a market capitalization of $9.51 million.

What is X T L Biopharmaceuticals' official website?

The official website for X T L Biopharmaceuticals is www.xtlbio.com.

How can I contact X T L Biopharmaceuticals?

X T L Biopharmaceuticals' mailing address is 5 BADNER STREET, RAMAT GAN L3, 4365603. The biopharmaceutical company can be reached via phone at 972-9955-7080 or via email at [email protected]

This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.